Skip to main content
Premium Trial:

Request an Annual Quote

IP Update: Recent Patents Awarded to Alnylam, Life Tech, and More

Premium

Title: Methods for Normalizing and for Identifying Small Nucleic Acids

Patent Number: 8,741,569

Filed: Oct. 23, 2009

Lead Inventor: Kai Lao, Applied Biosystems (Life Technologies)


Title: PHD2 Inhibition for Blood Vessel Normalization and Uses Thereof

Patent Number: 8,741,862

Filed: Jan. 20, 2010

Lead Inventor: Peter Carmeliet, Life Science Research Partners


Title: Compositions and Methods for Inhibiting Expression of Transthyretin

Patent Number: 8,741,866

Filed: March 1, 2012

Lead Inventor: Dinah Sah, Alnylam Pharmaceuticals


Title: RNA Sequence-specific Mediators of RNA Interference

Patent Number: 8,742,092

Filed: March 1, 2012

Lead Inventor: Thomas Tuschl, Max Planck Institute


Title: Methods of Novel Therapeutic Candidate Identification through Gene Expression Analysis in Vascular-related Diseases

Patent Number: 8,741,861

Filed: March 27, 2009

Inventor: David Mann, Vascular Biosciences


Title: Panel of microRNAs that Silence the MCL-1 Gene and Sensitize Cancer Cells to ABT-263

Patent Number: 8,742,083

Filed: Dec. 23, 2010

Lead Inventor: Dimitri Semizarov, AbbVie